BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stanbio Laboratory Release: ß-Hydroxybutyrate Applications Driving Sales Growth for Quantitative Diabetic Ketoacidosis Test


1/12/2012 2:37:14 PM

BOERNE, TX, January 12, 2012 – Stanbio Laboratory is announcing the total number of user-defined analyzer applications for its ß-hydroxybutyrate LiquiColor® enzymatic assay has increased to 19. There are ß-hydroxybutyrate analyzer applications available for many models of the most widely recognized industry brand names including Beckman Coulter, Olympus, Bayer, Ortho Clinical Diagnostics, Roche/Hitachi and Siemens.

“We’re experiencing accelerating acceptance of our ß-Hydroxybutyrate LiquiColor® assay,” said William R. Pippin, President of Stanbio Laboratory. “Many renowned medical centers have been using our ß-Hydroxybutyrate reagent because it provides a superior quantitative result in testing for diabetic ketoacidosis. We’re seeing more mid-sized and smaller hospitals moving away from the qualitative nitroprusside test to our quantitative enzymatic assay. To me, that says there’s a focus on providing a higher level of diabetic assessment and treatment at hospitals of all sizes,” Pippin added.

The assay is used for the determination of ß-hydroxybutyrate (blood ketone) in serum and plasma specimens. The measurement of ß-hydroxybutyrate is essential for the identification of complications of diabetes mellitus. During periods of metabolic acidosis the concentration of ketone bodies increases in blood and urine due to the lack of sufficient glucose in the cells. The major ketone body ß-hydroxybutyrate (~ 78 %) is not detectable with nitroprusside test strips commonly used for the detection of ketone bodies in urine; however, the Stanbio test is specific for ß-hydroxybutyrate, the predominant ketone body. It is not affected by interfering substances and shows a high linearity.

When compared with another commercially available chemistry system, the Stanbio ß-hydroxybutyrate method showed a correlation coefficient of 0.99 and a regression equation of y = 0.954x - 0.051.

The Stanbio ß-hydroxybutyrate LiquiColor® Reagent system is available as a set – R1: 1 x 50 mL, R2: 1 x 8.5 mL – and includes a 1.0 mmol/L standard (3 mL). Controls and linearity material are available separately.

Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 52nd year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.

EKF Diagnostics Holdings plc is a worldwide manufacturer of near-patient care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1c). It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is headquartered in London, the United Kingdom.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES